Please Note:
This profile was automatically generated using 4 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 4 references found on the Internet. This information has not been verified. Learn more...
Web References
-
1. Today's News
www.prnewswire.com/cgi-bin/sto - [Cached]Published on: 6/21/2002 Last Visited: 6/21/2002
ARC Pharmaceuticals also announced today the appointment of Dr. Jody Cashman to Senior Research Scientist. Dr. Cashman has over two decades of research experience at the Terry Fox Laboratory at the British Columbia Cancer Agency. Her experience with animal models and tissue cultures will be a valuable asset to the Company's pre-clinical research initiatives.
About ARC Pharmaceuticals Inc.:
ARC is a private biotechnology company focused on the development and commercialization of therapies for the treatment of cancer and inflammatory diseases. ARC combines polymeric drug delivery systems with antisense oligonucleotides and small molecule therapeutics to effectively target diseased sites and selectively inhibit proteins that cause disease.
This report may contain certain forward-looking information and statements concerning the Company's operation, performance and financial condition, including, in particular, the likelihood of securing licenses or other intellectual property for drug delivery systems and therapeutics for the treatment of cancer and inflammatory diseases, the likelihood of the completion of the development of new clinical products for the treatment of cancer and inflammatory diseases, and the likelihood of completing financings. -
2. ARC Pharmaceuticals Appoints Michael Diamond, MD and Victor Gomel, MD to its Scientific Advisory Board - ArcPharma.com
www.arcpharma.com/news_events/ - [Cached]Published on: 6/21/2002 Last Visited: 11/4/2007
ARC Pharmaceuticals also announced today the appointment of Dr. Jody Cashman to Senior Research Scientist. Dr. Cashman has over two decades of research experience at the Terry Fox Laboratory at the British Columbia Cancer Agency. Her experience with preclinical models and tissue culture will be a valuable asset to the Company's pre-clinical research initiatives. -
3. Yahoo - ARC Pharmaceuticals Appoints Michael Diamond, MD and Victor Gomel, MD to its Scientific Advisory Board
biz.yahoo.com/prnews/020621/va - [Cached]Published on: 6/21/2002 Last Visited: 6/21/2002
ARC Pharmaceuticals also announced today the appointment of Dr. Jody Cashman to Senior Research Scientist. Dr. Cashman has over two decades of research experience at the Terry Fox Laboratory at the British Columbia Cancer Agency. Her experience with animal models and tissue cultures will be a valuable asset to the Company's pre-clinical research initiatives.
About ARC Pharmaceuticals Inc.:
ARC is a private biotechnology company focused on the development and commercialization of therapies for the treatment of cancer and inflammatory diseases. ARC combines polymeric drug delivery systems with antisense oligonucleotides and small molecule therapeutics to effectively target diseased sites and selectively inhibit proteins that cause disease.
This report may contain certain forward-looking information and statements concerning the Company's operation, performance and financial condition, including, in particular, the likelihood of securing licenses or other intellectual property for drug delivery systems and therapeutics for the treatment of cancer and inflammatory diseases, the likelihood of the completion of the development of new clinical products for the treatment of cancer and inflammatory diseases, and the likelihood of completing financings.
